CA3014057C - Compositions et methodes pour le traitement du cancer du foie - Google Patents

Compositions et methodes pour le traitement du cancer du foie

Info

Publication number
CA3014057C
CA3014057C CA3014057A CA3014057A CA3014057C CA 3014057 C CA3014057 C CA 3014057C CA 3014057 A CA3014057 A CA 3014057A CA 3014057 A CA3014057 A CA 3014057A CA 3014057 C CA3014057 C CA 3014057C
Authority
CA
Canada
Prior art keywords
compound
hydrogen
methyl
nr5r6
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3014057A
Other languages
English (en)
Other versions
CA3014057A1 (fr
Inventor
Sheng-Yung Liu
Chih-Ming Chen
Original Assignee
Golden Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corp filed Critical Golden Biotechnology Corp
Priority claimed from PCT/US2017/018236 external-priority patent/WO2017143106A1/fr
Publication of CA3014057A1 publication Critical patent/CA3014057A1/fr
Application granted granted Critical
Publication of CA3014057C publication Critical patent/CA3014057C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Il est décrit des composés, des compositions et des méthodes de traitement du cancer du foie, à l'aide d'un nouveau composé anticancéreux. Il est décrit les composés de la formule I : (I) ou un sel connexe acceptable sur le plan pharmaceutique ou un solvate connexe.
CA3014057A 2016-02-17 2017-02-16 Compositions et methodes pour le traitement du cancer du foie Active CA3014057C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662296097P 2016-02-17 2016-02-17
US62/296,097 2016-02-17
PCT/US2017/018236 WO2017143106A1 (fr) 2016-02-17 2017-02-16 Compositions et méthodes pour le traitement du cancer du foie

Publications (2)

Publication Number Publication Date
CA3014057A1 CA3014057A1 (fr) 2017-08-24
CA3014057C true CA3014057C (fr) 2025-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
JP7689690B2 (ja) ヒドロキシ安息香酸誘導体、その方法および使用
TW202014186A (zh) 作為核轉運調節劑之化合物及其用途
CN102272101A (zh) 用于癌症治疗和成像的ca-ix特异性放射性药物
BR112020013672A2 (pt) compostos, composições, e métodos para tratamento de doenças que envolvem tecidos afetados por ácidos ou hipoxia
JP2022542669A (ja) Ｉｒａｋ４キナーゼ阻害剤及びその調製方法
WO2008131320A1 (fr) Dérivés de stilbène en tant que nouveaux agents thérapeutiques du cancer
CN106432014A (zh) 胺基硫醇类化合物及其制备方法和其在辐射防护中的应用
WO2022085523A1 (fr) Complexe, et son utilisation
ES2959891T3 (es) Producción de trans-[tetraclorobis(1H-indazol)rutenato (III)] y composiciones del mismo
CA3014057C (fr) Compositions et methodes pour le traitement du cancer du foie
EP3416630B1 (fr) Compositions et méthodes pour le traitement du cancer du foie
AU2019216757B2 (en) Mebendazole prodrugs with enhanced solubility and oral bioavailability
ES3040773T3 (en) Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy
US20230040251A1 (en) Benzimidazole derivative having fluorine-containing substituent, preparation and application thereof
US20140206645A1 (en) Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase
EP2816036B1 (fr) Promédicament à base de nitroimidazole
Hajipour et al. Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand
HK40000360A (en) Compositions and methods for treating liver cancer
NL2033714B1 (en) Multiplexing targeting and imaging agents
EP4071148A1 (fr) Promédicaments de dichalcogénure
AU2024331870A1 (en) Macrocyclic compound and use thereof
Chittamuru et al. New methodology for the preparation of 3-hydroxy-2-pyridinone (3, 2-hopo) chelators and extractants. Part 2: Reactions of alcohols, phenols, and thiols with an electrophilic 3, 2-hopo reagent
KR20250168470A (ko) 캄프토테신 유도체의 항체-약물 접합체 및 이의 용도
ES2609486T3 (es) Derivados de tiazolidinediona, su preparación y su utilización en el tratamiento de cánceres
Park et al. Anti-cancer activity of T-type calcium channel blocker in vivo